BioMed Research International

BioMed Research International / 2014 / Article
Special Issue

Research on Bacterial Virulence in the Developing Countries

View this Special Issue

Research Article | Open Access

Volume 2014 |Article ID 236260 | 11 pages | https://doi.org/10.1155/2014/236260

Phenotypic and Genotypic Characterization of Enterotoxigenic Escherichia coli Clinical Isolates from Northern Colombia, South America

Academic Editor: Chensong Wan
Received17 Jan 2014
Revised07 Apr 2014
Accepted08 Apr 2014
Published30 Apr 2014

Abstract

Enterotoxigenic Escherichia coli (ETEC) are major causes of childhood diarrhea in low and middle income countries including Colombia, South America. To understand the diversity of ETEC strains in the region, clinical isolates obtained from northern Colombia children were evaluated for multiple locus sequencing typing, serotyping, classical and nonclassical virulence genes, and antibiotic susceptibility. Among 40 ETEC clinical isolates evaluated, 21 (52.5%) were positive for LT gene, 13 (32.5%) for ST gene, and 6 (15%) for both ST and LT. The most prevalent colonization surface antigens (CS) were CS21 and CFA/I identified in 21 (50%) and 13 (32.5%) isolates, respectively. The eatA, irp2, and fyuA were the most common nonclassical virulence genes present in more than 60% of the isolates. Ampicillin resistance (80% of the strains) was the most frequent phenotype among ETEC strains followed by trimethoprim-sulfamethoxazole resistance (52.5%). Based on multiple locus sequencing typing (MLST), we recognize that 6 clonal groups of ETEC clinical isolates circulate in Colombia. ETEC clinical isolates from children in northern Colombia are highly diverse, yet some isolates circulating in the community belong to well-defined clonal groups that share a unique set of virulence factors, serotypes, and MLST sequence types.

1. Introduction

Enterotoxigenic Escherichia coli (ETEC) are important enteric pathogens worldwide, especially affecting children in developing countries [1, 2]. ETEC strains are responsible for ~400 million diarrheal cases annually in children less than 5 years of age, resulting in 300,000 to 500,000 deaths, and they are the most common causes of traveller’s diarrhea, accounting for 50% of all traveler’s diarrhea episodes [3, 4]. ETEC strains belong to a highly diverse group of strains with respect to enterotoxin type, colonization surface antigens (CSs), serotypes, and ancestral lineages [58].

ETEC strains are defined by the presence of plasmid-encoded heat-labile toxin (LT) and/or the heat-stable toxins (ST) [9, 10]. ST, a guanylin homologue expressed in intestinal cells, is a heterogeneous peptide with two major subtypes STa, present predominantly in human ETEC isolates, and STb, present predominantly in animal ETECs [11]. Both subtypes induce diarrhea in piglets [12]. STa is further subdivided in two variants, STh and STp (from their initial detection among pigs) that have been reported in ETEC clinical isolates from different parts of the world [11, 13]. ETEC strains also express plasmid- or chromosomally encoded colonization surface antigens (CSs). These heterogeneous pili or nonpili surface structures are believed to promote small intestine ETEC colonization and they are currently considered important vaccine targets. Twenty-two different CSs have been identified among human ETEC of diverse geographic origins [14, 15]. ETEC isolates may produce one or more CSs, while some isolates do not express any or do not produce recognizable CSs [2]. LT and ST toxin types and CSs profiles from clinical ETEC isolates vary from one geographic region to another [2, 6, 16, 17].

ETEC also expresses a variety of nonclassical virulence factors that may be essential for pathogenicity and promising vaccine targets. Among nonfimbrial adhesins/invasins, Tia is a 25 kD outer membrane protein that interacts with host cell surface proteoglycans and by itself is sufficient to promote bacterial adherence and epithelial cell invasion when cloned into laboratory E. coli strains [18, 19]. The labile enterotoxin output gene (leoA), encoding a cytoplasmic protein with GTPase activity, is required for maximal LT secretion. Both Tia and LeoA are encoded in a 46-Kb pathogenicity island (Tia-PAI) [20, 21]. The TibA protein encodes a glycosylated autotransporter that mediates adhesion to surface epithelial cells, autoaggregation, and biofilm formation [22, 23]. The etpBAC locus encodes three proteins: EtpA, a 170 kDA secreted glycoprotein, EtpB a transport pore, and EtpC, a putative glycosyltransferase required both for optimal secretion and glycosylation of EtpA. The EtpA glycoprotein appears to act as a molecular bridge, binding the exposed regions of FliC at the flagellar tip and host surface structures [24, 25]. EatA, a serine protease autotransporter of the Enterobacteriaceae (SPATE) family, was shown to increase ETEC virulence in an animal model, by degrading mucin and facilitating LT release [25, 26]. Finally, the irp2 and fyuA genes, located in the high-pathogenicity island (HPI), encode a yersiniabactin-like iron scavenging system [27].

ETEC is the leading cause of diarrhea in children less than 5 years of age in Colombia, South America [28, 29], yet no information is available of the phenotypes and genotypes associated with these strains. The objectives of this study were to identify the most common genotypes associated with Colombian ETEC clinical isolates with respect to enterotoxins, CSs, nonclassical virulence genes, and genomic profiles and to determine the most common ETEC O:H serotypes and antimicrobial susceptibility patterns. Recognizing the most frequent circulating strains including the most common potential antigens may help prioritize ETEC diarrhea prevention measures including vaccine development research strategies.

We found that ETEC isolates were positive for LT, ST, or both ST/LT genes, the most prevalent CSs were CS21 and CFA/I, and the most common nonclassical virulence genes were eatA, irp2, and fyuA. Based on MLST, serotyping, and virulence genotype, Colombian ETEC clinical isolates showed broad genetic diversity, yet 6 distinctive clonal groups were identified.

2. Materials and Methods

2.1. Strains Used in This Study

Thirty-two ETEC clinical isolates from children less than 5 years of age with diarrhea and 8 ETECs obtained from healthy children from two studies were used. Seven of these ETEC strains came from children with diarrhea from a prevalence study previously described in two Caribbean cities in Colombia [29]. The remaining ETEC strains were obtained from case-control studies of children less than 5 years of age also in Cartagena, Colombia [28]. Twenty-five strains were from cases and 8 strains from healthy controls (Table S1). All ETEC clinical isolates identified from the two epidemiological studies mentioned above were included in the present study. These isolates were identified by multiplex PCR using ST primers (ST.F-5′GCTAAACCAGTA(G/A)GGTCTTCAAAA3′ and ST.R- 5′CCCGGTACA(G/A)GCAGGATTACAACA 3′) and LT primers (LT.F- 5′GCACACGGAGCTCCTCAGTC-3′ and LT.R- 5′TCCTTCATCCTTTCAATGGCTTT 3′) [29]. Reference ETEC and non-ETEC strains were used as positive and negative controls for all assays and they are described in Table 1. ETEC strains carrying different CS genes, used as controls for PCR detection assays, were kindly provided by Dr. Steven Savarino from the Naval Medical Research Center.


TypeStrainSerotypeToxin typeCS typeSource

ETECE24377AO139:H28LT/ST CS1, CS3 Levine et al., 1984 [39]
ETEC910980-2O25:NM STh CS4, CS6 NMRCb
ETECW6520AO114:H49 LT CS7 NMRC
ETECWS6866B-2NK LT CS8 (i.e., CFA/III) NMRC
ETECM421C1NK LT/STh CS5, CS6 VUc
ETECWS6474DO68:H12 LTST CS12 (i.e., PCFO159) NMRC
ETEC911205O64:NM LT CS13 (i.e., PCFO9) NMRC
ETECE7476AO166:H27 STh CS14 NMRC
ETEC8786O117:H4 ST CS15 (i.e., 8786) NMRC
ETECWS6788AO8:H9 LT CS17 NMRC
ETECARG-2O20:H− LT CS18 (i.e., PCFO20) NMRC
ETECDS26-1O8:H9LTCS19NMRC
ETECWS7179A-2O17:H45LTSTCS20NMRC
ETEC H10407aO78:H11LT/STh-STpCFA/IEvans et al., 1975 [40]
ETEC145C2NKLT/SThCS2, CS3, CS21VU
ETECE9034ANKLT/SThCS3/CS21Levine et al., 1984 [39]
E. coli DH5 NoneNoneVU

used as a positive control for nonclassical virulence factors.
bNMRC refers to Naval Medical Research Center.
cVU refers to Gomez-Duarte’s laboratory collection at Vanderbilt University.
NK refers to not known.
2.2. DNA Techniques

Unless otherwise specified, standard methods were used for plasmid isolation, genomic DNA isolation, and agarose electrophoresis DNA separation [30]. E. coli clinical isolates were processed for isolation of genomic DNA as previously described [31]. In brief, overnight liquid cultures were centrifuged, and the pellet was resuspended in water, boiled for 10 min, and centrifuged again. The supernatant containing a crude DNA extract was used as a DNA template for PCR assays.

2.3. DNA Amplification

Detection of STh, STp, and LT toxin genes and 19 CSs genes was performed by multiplex polymerase chain reaction (mxPCR) assays as described before [32]. CSs genes tested included CFA/I, CS1, CS2, CS3, CS4, CS5, CS6, CS7, CS8, CS12, CS13, CS14, CS15, CS17, CS18, CS19, CS20, CS21, and CS22. Confirmatory single PCR was performed on strains positive on the multiplex PCR assays. Detection of Tia, LeoA, TibA, EatA, EtpA, EtpB, FyuA, and Irp2 genes was done by single PCR assays as described before [33].

2.4. Multilocus Sequence Typing (MLST)

Genetic diversity of ETEC strains was analysed by multilocus sequence typing (MLST) by using the University College Cork E. coli MLST scheme (http://mlst.warwick.ac.uk), which is based on sequencing of internal regions of 7 housekeeping genes adk, fumC, gyrB, icd, mdh, purA, and recA [34]. Phylogenetic trees were constructed using the Phylogeny.fr software available online at http://www.phylogeny.fr/version2_cgi/index.cgi by the cluster W method [35]. Forty seven-gene DNA sequence concatamers for each ETEC strain as well as 4 E. coli control sequence concatamers from ancestral groups A, B1, B2, and D were assembled and aligned using the ClustalW program. The phylogenetic tree using the PhyML program was constructed using bootstrapping procedure (100 straps) [35, 36]. Some ETEC strains were assigned to clonal groups. A clonal group was defined as a group of more than one ETEC strains that do not seem to share ancestral origin with other ETEC and that have at least 2 strains with identical MLST DNA sequence.

2.5. Serotyping

Serotyping was performed at the E. coli Reference Center, Pennsylvania State University, according to standard methods for determining the O antigen [37]. H typing was performed using a fliC PCR-RFLP method [38].

2.6. Antimicrobial Susceptibility Testing

Antimicrobial susceptibility to 12 different antibiotics was tested using BD BBL Sensi-Disc Susceptibility Test Discs methods (Becton, Dickinson andCompany. © 2012 BD). Strain activity was tested against cefazolin (CZ), ceftriaxone (CRO), ampicillin (AM), amoxicillin/clavulanic acid (AMC), ceftazidime (CAZ), cefuroxime (CMX), cefepime (FEP), ciprofloxacin (CIP), gentamicin (GM), Meropenem (MEM), sulfamethoxazole (STX), and piperacillin tazobactam (TZP).

3. Results

3.1. Colombian ETEC Clinical Isolates Carry LT, ST, and LT/ST Enterotoxins

ETEC clinical isolates from children with diarrhea and with no diarrhea previously described were evaluated for the presence of LT and/or ST enterotoxin genes (See Table S1) [28, 29]. As shown in Table 2, LT-containing ETEC strains were the most frequently detected group (52.5%) followed by ST-containing ETEC strains (32.5%) and ETEC-LT/ST strains (15%). All ETEC-ST strains tested were positive for the STh variant. No STp variants were identified.


Toxin gene typeTotal number of isolatesaCF type (s) producedNumber (%) of isolates

LT21CS21 + CFA/I1 (4.7)
CS21 + CS63 (14.2)
CS21 + CS121 (4.7)
CS21 + CS71 (4.7)
CS21 + CS2 + CS31 (4.7)
CS11 (4.7)
CS71 (4.7)
CS192 (9.5)
CS61 (4.7)
CF undetectedb9 (42.8)

LT-ST6CS211 (16.6)
CS5 + CS64 (66.6)
CS51 (16.6)

ST13CS21 + CFA/I12 (92.3)
CF undetectedb1 (8.3)

isolates positive for any enterotoxin and positive or negative for any CSs.
bCSs undetected by PCR reaction.

3.2. CSs Were Frequently Found among ETEC Clinical Isolates

CSs are piliated and nonpiliated structures believed to be involved in ETEC colonization of the human gut. In our study 75% of all clinical isolates were positive for at least one CS and 25% were negative for any CS (Table 2). Among ETEC-associated CS described in the literature, 10 different types of CSs were detected among Colombian ETEC isolates. Alone or in association, the most prevalent ETEC CSs were CS21, CFA/I, CS6, and CS5, present in 50.0%, 32.5%, 20%, and 12.5%, respectively.

Detection of CS21 was present in 12 (92.3%) out of 13 ETEC strains containing ST, followed by 7 (33.3%) out of 21 ETEC strains containing LT and only 1 (16.6%) out of 6 ETEC strains containing LT and ST toxins. CFA/I was found in 12 (92.3%) out of 13 ETEC strains containing ST strains and only in 1 (4.7%) out of 21 ETEC strains carrying LT. CFA/I was not detected among ETEC containing ST and LT toxins. CS6 was found in 4 (19%) out 21 LT-containing ETEC strains and in 4 (66.6%) out of 6 ST and LT containing ETEC strains. CS5 was only found among 5 (83.3%) out 6 ST/LT-containing ETEC strains. CS1, CS2, CS7, CS12, CS13, and CS17 CSs were only detected among LT-containing ETEC strains. Among CS-negative ETEC, 9 out 21 (42.8%) were LT-containing ETEC strains, and only 1 out of 12 (8.3%) were ST-containing ETEC strains.

CFA/I was detected in association with CS21 (Table 2) in 13 ETEC strains, 12 strains of them containing ST and one LT. No ETEC with ST/LT combination contained this CS pattern. The CS5-CS6 pattern was the second most common CSs combination present in 4 out of 40 ETEC strains (10.0%), all of them positive for ST and LT ETEC strains. The CS21-CS6 was the third most common CSs pattern only present in 3 out of 42 ETEC strains (7.1%), all positive for LT.

3.3. Nonclassical Virulence Genes Were Detected among Colombian ETEC Isolates

Nonclassical virulence factors, believed to essential contributors to the pathogenesis of ETEC diarrhea, include factors associated with adherence, invasion, enterotoxin secretion, and iron acquisition. The irp2, fyuA, and eatA genes, present in 33 (82.5%), 30 (75%), and 29 (72.5%) ETEC isolates, respectively, were the most frequently detected nonclassical virulence ETEC genes (Figure 1). In contrast, strains carrying the tia-PAI-associated genes were uncommon. Only 1 (2.5%) strain was positive for the leoA gene and 7 (17.5%) for the tia gene. The etpA and etpB genes encoded by the same plasmid that harbors genes for toxins and CFA/I in strain H10407 were both detected in 18 (45%) ETEC isolates. The tibA gene was only detected in 7 (17.5%) ETEC isolates.

3.4. Phylogenetic and MLST Results

To evaluate the genetic relatedness among Colombian ETEC isolates and with ancestral E. coli strains, MLST was conducted and a phylogenetic tree was analyzed. MLST sequences from E. coli pathogens representing ancestral E. coli groups A, B1, B2, and D were included in the analysis as controls. The phylogenetic tree constructed from Colombian ETEC MLST sequences is highly diverse as demonstrated by the extended branching (Figure 2). Despite genetic diversity, most ETEC strains seem to be derived from E. coli ancestral groups A and B1, as determined by the phylogenetic tree evolutionary relationships using E. coli control strains MLSTs from ancestral groups A, B1, B2, and D. Only a minority of the ETEC strain MLSTs were associated with E. coli strain MLSTs from phylogenic groups B2 and D.

Nineteen (47.5%) ETEC strains are clustered into six allelic groups. Based on identical MLST sequences within each cluster, we have designated these clusters as clonal groups 1 to 6. Based on evolutionary relationships using E. coli control strain MLSTs, clonal groups 1, 2, 4, 5, and 6 are associated with ancestral groups A and B1, while clonal group 3 MLST is associated with ancestral group D and B2. Analysis of MLST sequence types (SeqT) found that all 40 ETEC isolates have one designated specific SeqT (Table 3). SeqT is defined as the allelic profile resulting from the seven alleles assigned to each one of the 7 house-keeping loci sequences. In this study, we are reporting three new SeqTs, SeqT 4238, SeqT 4239, and SeqT 4252, for strains COCt26, COCt234, and COCt159, respectively. As part of the MLST new SeqT 4252, we have also reported a new icd gene DNA sequence designated icd454 for the COCt159 ETEC strain. Twenty Colombian ETEC strains had MLST SeqT previously reported as ETEC. The most common MLST SeqT among Colombian ETECs isolates was the 2332 found in 7 (17.5%) ETEC isolates (Table 3). Five ETEC isolates had MLST SeqT previously observed among non-ETEC pathotypes while12 ETEC isolates had SeqT not previously observed among E. coli pathotypes.


Origin of ETEC isolates number (%)SeqTAssociated pathotypea
Child with diarrheaHealthy childTotal

617 (17.5)SeqT2332ETEC
101 (2.5)SeqT849ETEC
202 (5.0)SeqT88ETEC
101 (2.5)SeqT100ETEC
011 (2.5)SeqT4ETEC
011 (2.5)SeqT94ETEC
202 (5.0)SeqT1312ETEC
101 (2.5)SeqT731ETEC
112 (5.0)SeqT10ETEC, EAEC, EPEC, ExPEC
101 (2.5)SeqT34EAEC
202 (5.0)SeqT38EAEC
101 (2.5)SeqT501EAEC
011 (2.5)SeqT23EHEC
101 (2.5)SeqT2066Commensal
101 (2.5)SeqT216Commensal
101 (2.5)SeqT3855ETEC
202 (5.0)SeqT641Unknown
202 (5.0)SeqT173Unknown
1b01 (2.5)SeqT155ETEC, EAEC, ExPEC
4c04 (10.0)SeqT443Unknown
01d1 (2.5)SeqT1623Unknown
1e01 (2.5)SeqT2067Unknown
101 (2.5)SeqT4238fNew SeqT
101 (2.5)SeqT4239fNew SeqT
101 (2.5)SeqT4252gNew SeqT

34 (85.0)6 (15.0)40 (100.0)

Associated pathotype according to MLST Databases at the ERI, University College Cork. bSingle mutation in fumC at position 158. cSingle mutation in icd at position 158. dSingle mutation in purA at position 260. eMutations in icd at position 110 and fumC at position 153. fNew sequence types submitted to the MLST Databases at the ERI, University College Cork. gNew SeqT submitted to MLST database; in addition, the new icd sequence for this strain was assigned number icd 454.
3.5. Colombian ETEC Isolates Belong to a Highly Diverse Group of O:H Serogroups

O:H serogroups identification was conducted to determine the most common Colombian ETEC serotypes. Twenty-nine (72.5%) ETEC strains belonged to 16 different O serogroups (Figure 2). The most common O groups were O128 and O167 present in 8 (28.6%) and 4 (14.3%) of isolates, respectively. In addition, 7 ETEC isolates with rough colonies lacked side chains thus were classified as nontypeable with respect to O antigen. Thirty-four (85%) of ETEC isolates belonged to 13 different H types. The most common H serogroups were H45 type present in 11 (27.5%) ETEC isolates. Other H serogroups identified in 3 or more strains included H5 and H16. Five (14.7%) strains were H5 and 3 (8.8%) were H16. The most common O:H combination identified was the O128:H45 serotype present in 8 (20%) of the strains and 7 of them within the same MLST clonal group. Serogroup O167:H7 was present in 4 (10%) ETEC isolates that belong to clonal group 2. Less frequent serotypes combinations associated with MLST-based clonal groups included O153:H18 (clonal group 3) and O25:H16 (clonal group 4).

3.6. Colombian ETEC Isolates Have Low Level of Antibiotic Resistance

To evaluate ETEC clinical isolates for antibiotic susceptibility conventional disk antibiograms were performed (Table 4). Ampicillin, trimethoprim-sulfamethoxazole, cefazolin, and amoxicillin clavulanate resistance was detected among 27 (67.5%), 20 (50%), 6 (15%), and 2 (5%) isolates, respectively. No resistance to ceftriaxone, ceftazidime, cefepime, ciprofloxacin, and piperacillin/tazobactam was detected among ETEC isolates. Resistance to gentamicin was detected in one strain only.


AntibioticsETEC isolates number (%)
SusceptibleIntermediateResistant

Cefazolin (CZ) 29 (72.5)5 (12.5)6 (15.0)
Ceftriaxone (CRO) 40 (100)0 (0)0 (0)
Ampicillin (AM) 8 (20.0)5 (15.0)27 (67.5)
Amoxicillin/clavulanic acid (AMC) 25 (62.5)13 (32.5)2 (5.0)
Ceftazidime (CAZ) 40 (100)0 (0)0 (0)
Cefuroxime (CXM) 39 (97.5)1 (2.5)0 (0)
Cefepime (FEP) 40 (100)0 (0)0 (0)
Ciprofloxacin (CIP) 40 (100)0 (0)0 (0)
Gentamicin (GM) 39 (97.5)0 (0)1 (2.5)
Meropenem (MEM) 39 (97.5)0 (0)1 (2.5)
Sulfamethoxazole (STX) 17 (42.5)1 (2.5)22 (55.0)
Piperacillin/tazobactam (TZP) 40 (100)0 (0)0 (0)

Four ETECs resistant to a single antibiotic (AM); 15 resistant to 2 antibiotics (AM and STX), 7 ETEC resistant to 3 antibiotics (AM-STX-CZ or AM-STX-GM or AM-STX-AMC), and a single ETEC resistant to 4 antibiotics (AM, STC, CZ, and AMC).

3.7. Features Shared among ETEC Clonal Groups Including O:H Serogroup, Classical and Nonclassical Virulence Genes, and Antibiotic Resistance Profile

Nineteen (47.5%) Colombian ETEC isolates belong to 6 clonal groups. Clonal group 1 contained 7 ETEC isolates defined by identical MLST sequence and sequence type (2332). All clonal group 1 ETECs had identical O:H serotype and virulence genes (STh enterotoxin, CS21-CFA/I CSs and non-classical virulence factors) and they were resistant to ampicillin and sulfamethoxazole (Table 5). Strains in clonal group 1 were isolated from different individuals at different year periods. ETEC isolates from clonal group 2 with 4 share the same serotype as well as classical and nonclassical virulence factors. Three of them were resistant to ampicillin and sulfamethoxazole. Clonal groups 3 and 4 contain only two ETEC strains each with the same serotype. Clonal groups 5 and 6 do not seem to share the same serotype.


IsolateClassical virulence factorsa Non-classical virulence factorsClonal groupeSeqT groupfSerotype Antibiotic resistanceh
EnterotoxinsCSc
STbLT

COCt122+CFA/I, CS21eatA, irp2, fyuA, etpA, etpB 12332O128:H45AM, STX
COCt129+CFA/I, CS21eatA, irp2, fyuA, etpA, etpB 12332O128:H45AM, STX
COCt142+CFA/I, CS21eatA, irp2, fyuA, etpA, etpB 12332O128:H45AM, STX
COCt249+CFA/I, CS21eatA, irp2, fyuA, etpA, etpB 12332O128:H45AM, STX
COCt253+CFA/I, CS21eatA, irp2, fyuA, etpA, etpB 12332O128:H45AM, STX
COCt310+CFA/I, CS21eatA, irp2, fyuA, etpA, etpB 12332O128:H45AM, STX, CZ
COCt140cc+CFA/I, CS21eatA, irp2, fyuA, etpA, etpB 12332O128:H45AM, STX, AMC

COCt124++CS5, CS6eatA, tia 2443gO167:H5ND
COCt201++CS5, CS6eatA, tia 2443gO167:H5AM, STX
COCt235++CS5, CS6eatA, tia, irp2, fyuA 2443gO167:H5AM, STX
1COSc36++CS5, CS6eatA, tia 2443gO167:H5AM, STX

COCt 161+NDdirp2, fyuA 338O153:H18AM, STX, CZ
COCt 285+CFA/I, CS21eatA, irp2, fyuA, etpA, etpB 338O153:H18AM, STX

1COCt40+CS6, CS21eatA, irp2, fyuA 41312O25:H16AM, STX, CZ
1COSc61+CS6, CS21eatA, irp2, fyuA 41312O25:H16AM, STX, CZ

COCt200 + CS21, CFA/I eatA, irp2, fyuA, etpA, etpBirp2, fyuA 5 88 O128:H45 AM, STX
1COCt43 + CS18 5 88 O8:H9 AM, STX, CZ

COCt131 + CS7, CS21 eatA, tibA, irp2, fyuA, etpA, etpB 6 137 O78:H10 AM, STX
COCt337 + CS7 eatA, tibA, irp2, fyuA, etpA, etpB 6 137 O(−):H(−) AM, STX, CZ

ST, heat-stable toxin; heat-labile toxin.
bAll ETEC TS positives were positive for the STh variant.
cCS refers to colonization surface antigens.
dND: not detected.
eBased on phylogenetics (see Section 2).
fAs determined by EcMLST (http://mlst.ucc.ie/mlst/dbs/Ecoli).
gETEC strains with SeqT 443 that contain a single icd locus variant. The icd gene has 517/518 matches (mutation in T-229).
hResistance to AM, ampicillin; STX: sulfamethoxazole; CZ: cefazolin; AMC: amoxicillin /clavulanic acid.

4. Discussion

ETEC diarrhea is a leading cause of morbidity and mortality in children less than 5 year of age living in underserved geographic areas of the world and a leading cause of traveler’s diarrhea. ETEC is also a leading cause of morbidity in Colombia, a middle income country in Latin America. In this study, we show that northern Colombian ETEC clinical isolates from children less than 5 years of age are a highly diverse group of strains based on MLST, serotyping, and presence of classical and nonclassical virulence factors, yet 6 clonal groups were identified. A limitation of our study is the limited number of ETEC strains tested and also the strains origin is limited to two mayor urban centers in northern Colombia. Accordingly we will confine our analysis and conclusions to northern Colombian ETEC strains. Further studies will be necessary to evaluate ETEC diversity from all Colombian corners to better define ETEC Colombian virulence and colonization gene diversity and strain clonality.

LT, the most frequently toxin type found in the Colombian ETEC isolates, was detected in 67.5% of strains, whether alone or in combination with ST [41]. This entorotoxin pattern was also reported in Bangladesh and Peru, where LT-producing ETEC was seen in 52% and 72% of the cases, respectively [42, 43]. This is in contrast with other studies from Indonesia and Chile showing that ST-producing ETEC predominated [33, 44]. ST enterotoxin variants STp and STh induce disease in humans, and differentiation of STp from STh may help identify differences in the epidemiology of these two strains [45]. In this study, all Colombian ETEC strains positive for ST were only positive for the STh variant; no ETEC strains positive for STp were identified. Low frequency of STp ETEC strains was also reported among Brazilian, Bolivian, and Chilean ETEC clinical isolates suggesting that STh toxin predominates among Latin American ETECs [33, 46, 47].

CS21 was the most commonly identified CS among Colombian ETEC isolates, followed by CFA/I and CS6. The association of CS21 and CFA/I among ETECs was also remarkable. Similar findings were reported in Chile where CS21 was found in association with CFA/I [33]. In contrast, CFA/I and CS14 predominated among Bolivian ETEC strains [46]. CS21 has also been identified in ETEC strains from Argentina, Brazil, Bolivia, Egypt, and Bangladesh [33, 46, 4851].

CS21 is long rod-like fimbria that directs adhesion to intestinal epithelial cells and mediate self-aggregation and twitching motility, and it is involved in pathogenesis [5254]. In this study, CS21 was more often associated with LT producer Colombian ETEC strains. ETEC strains expressing CS21 tend to be isolated in higher proportion among pediatric populations [50]. It is likely that the higher proportion of CS21 among Colombian ETECs is due to the fact that all ETEC strains were obtained from children less than 5 years of age. CFA/I, CS6, and CS21 were detected among all ETEC toxins profiles, demonstrating their extended distribution. Similarly, CFA/1, CS6, and CS21 have been widely distributed among ETEC strains worldwide [2, 14]. In 10 (25%) of Colombian ETEC isolates, no CSs were identified. This indicates that these 10 ETECs do not express any known CSs, they contain CSs variants unable to be recognized by conventional PCR, or they contain unknown CSs unable to be recognized with current PCR assays [2, 55]. These strains may express novel CSs pending to be identified.

Nonclassical virulence genes were detected among Colombian ETEC strains. The eatA, irp2, and fyuA were the most frequent. These genes are known to be associated with the ETEC HPI pathogenicity island [27]. The distribution of nonclassical virulence genes among Colombian ETEC strains is similar to Chilean ETEC strains, except that etpA and etpB are present at lower rates (18%) [33]. The tia and leoA genes were also detected at low frequency, similar to the reported frequency among strains from Bolivia, Chile, Guatemala, Mexico, and India [33, 41, 56]. In contrast, irp2 and fyuA genes were detected in more than 70% of the strains as previously described among Chilean strains [33].

Colombian ETEC strains have a widely diverse phylogenetic distribution represented in 17 known MLST sequence types. Ample diversity among human ETEC strains from different geographic regions worldwide was reported previously [8]. Colombian ETECs segregated with any ancestral E. coli clonal groups A, B1, B2, and D. This is consistent with the idea that ETEC strains are representative members of distinct ETEC lineages [8, 10]. In regard to serotyping, 16 different O groups and 13 H groups were detected among Colombian ETECs. Studies on ETEC strains from different regions of the world have reported 78 different O serogroups and 34 H serogroups, indicating that ETEC serotype diversity among Colombia ETEC is similar to serotype diversity reported in elsewhere [57].

Despite serogroup diversity, there is an association between serogroups and genetic linkages as demonstrated by the serotype-specific clonal clusters among ETEC Brazilian strains [58]. In our study, 6 clonal groups were identified based on MLST and some of them shared similar serotypes, CSs, and nonclassical virulence genes. The MLST sequence types for each of clonal groups 1 to 6 that had been described before in the E. coli MLST database suggest that these clonal groups may circulate not only in Colombia but also in other geographic regions. The Colombian ETEC clonal group 1 with MLST SeqT2332 was associated with O128 serogroup. This serotype was previously described among ETEC strains in Bangladesh, Brazil, Egypt, and Tunisia [7, 5860]. The SeqT2332 was described in Mexico according to the University College Cork E. coli MLST Database, yet it is not frequently detected among Bolivian or Mexican ETEC strains. SeqT443 is the second most common sequence type among Colombian ETECs. SeqT423 and SeqT443 predominate in Mexican ETEC isolates while SeqT398 predominates in Guatemala and Mexico ETEC strains [61]. While limited studies are available in Latin America on phylogeny of ETEC clinical isolates using MLST schemes, it is suggested based on the available data that ETEC are highly diverse in Latin America. This study has tested a limited number of ETEC strains and the origin of these isolates is also limited to two mayor urban centers in northern Colombia. Accordingly, we confine our analysis and conclusions to Northern Colombian ETEC strains. Further studies are necessary to evaluate ETEC diversity from all Colombian corners to better define Colombian ETEC genotype, phenotype, clonality, and genetic diversity.

5. Conclusion

In summary, ETEC clinical isolates from northern Colombia are a highly diverse group of intestinal pathogens that possess multiple combinations of classical and nonclassical virulence factors as well as MLST sequence types and serotypes. Despite the genotypic and phenotypic diversity, 6 well-defined clonal groups were identified. These predominant clonal groups have been circulating within the community for several years and they share an almost identical set of classical and nonclassical virulence factors as well as MLST and serotype. Further research in Colombia and other Latin American countries is necessary to identify the most prevalent ETEC-associated virulence factors with immunoprotection potential. Promising ETEC vaccine candidates should take into account predominant antigens, antigenic diversity, and geographic variation.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

This work was supported in part by the Robert Wood Johnson Foundation Grant no. 65879 through the Harold Amos Medical Faculty Development Program and by the NIH-NIAID R01AI095346 awarded to Oscar G. Gómez-Duarte. The authors are grateful with Dr. Steven Savarino for his insightful comments on the manuscript and for providing control ETEC strains for this study.

Supplementary Materials

The supplementary table S1 provides the complete list of ETEC clinical isolates used in the present study. This table includes information on source, date and place of strain isolation, as well as data on virulence genes (enterotoxins, CSs and non-classical virulence factors), serotype, MLST sequence type and antimicrobial susceptibility.

  1. Supplementary Tables

References

  1. K. L. Kotloff, J. P. Nataro, W. C. Blackwelder et al., “Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study,” The Lancet, vol. 382, no. 9888, pp. 209–222, 2013. View at: Publisher Site | Google Scholar
  2. F. Qadri, A.-M. Svennerholm, A. S. G. Faruque, and R. B. Sack, “Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention,” Clinical Microbiology Reviews, vol. 18, no. 3, pp. 465–483, 2005. View at: Publisher Site | Google Scholar
  3. R. I. Walker, D. Steele, and T. Aguado, “Analysis of strategies to successfully vaccinate infants in developing countries against enterotoxigenic E. coli (ETEC) disease,” Vaccine, vol. 25, no. 14, pp. 2545–2566, 2007. View at: Publisher Site | Google Scholar
  4. World Health Organization (WHO), “Weekly epidemiological record,” 2006, http://www.who.int/wer/2006/wer8111.pdf. View at: Google Scholar
  5. J. Ouyang-Latimer, N. J. Ajami, Z.-D. Jiang et al., “Biochemical and genetic diversity of enterotoxigenic Escherichia coli associated with diarrhea in United States students in Cuernavaca and Guadalajara, Mexico, 2004–2007,” The Journal of Infectious Diseases, vol. 201, no. 12, pp. 1831–1838, 2010. View at: Publisher Site | Google Scholar
  6. C. Rodas, J. D. Klena, M. Nicklasson, V. Iniguez, and Å. Sjöling, “Clonal relatedness of enterotoxigenic Escherichia coli (ETEC) strains expressing LT and CS17 isolated from children with diarrhoea in La Paz, Bolivia,” PLoS ONE, vol. 6, no. 11, Article ID e18313, 2011. View at: Publisher Site | Google Scholar
  7. H. I. Shaheen, S. B. Khalil, M. R. Rao et al., “Phenotypic profiles of enterotoxigenic Escherichia coli associated with early childhood diarrhea in rural Egypt,” Journal of Clinical Microbiology, vol. 42, no. 12, pp. 5588–5595, 2004. View at: Publisher Site | Google Scholar
  8. H. Steinsland, D. W. Lacher, H. Sommerfelt, and T. S. Whittam, “Ancestral lineages of human enterotoxigenic Escherichia coli,” Journal of Clinical Microbiology, vol. 48, no. 8, pp. 2916–2924, 2010. View at: Publisher Site | Google Scholar
  9. F. C. Dorsey, J. F. Fischer, and J. M. Fleckenstein, “Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli,” Cellular Microbiology, vol. 8, no. 9, pp. 1516–1527, 2006. View at: Publisher Site | Google Scholar
  10. J. M. Fleckenstein, P. R. Hardwidge, G. P. Munson, D. A. Rasko, H. Sommerfelt, and H. Steinsland, “Molecular mechanisms of enterotoxigenic Escherichia coli infection,” Microbes and Infection, vol. 12, no. 2, pp. 89–98, 2010. View at: Publisher Site | Google Scholar
  11. I. Bölin, G. Wiklund, F. Qadri et al., “Enterotoxigenic Escherichia coli with STh and STp genotypes is associated with diarrhea both in children in areas of endemicity and in travelers,” Journal of Clinical Microbiology, vol. 44, no. 11, pp. 3872–3877, 2006. View at: Publisher Site | Google Scholar
  12. W. Zhang, D. C. Robertson, C. Zhang, W. Bai, M. Zhao, and D. H. Francis, “Escherichia coli constructs expressing human or porcine enterotoxins induce identical diarrheal diseases in a piglet infection model,” Applied and Environmental Microbiology, vol. 74, no. 18, pp. 5832–5837, 2008. View at: Publisher Site | Google Scholar
  13. N. Konishi, H. Obata, C. Monma, A. Nakama, A. Kai, and T. Tsuji, “Bacteriological and epidemiological characteristics of enterotoxigenic Escherichia coli isolated in Tokyo, Japan, between 1966 and 2009,” Journal of Clinical Microbiology, vol. 49, no. 9, pp. 3348–3351, 2011. View at: Publisher Site | Google Scholar
  14. W. Gaastra and A.-M. Svennerholm, “Colonization factors of human enterotoxigenic Escherichia coli (ETEC),” Trends in Microbiology, vol. 4, no. 11, pp. 444–452, 1996. View at: Publisher Site | Google Scholar
  15. S. D. Isidean, M. S. Riddle, S. J. Savarino, and C. K. Porter, “A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression,” Vaccine, vol. 29, no. 37, pp. 6167–6178, 2011. View at: Publisher Site | Google Scholar
  16. M. R. Rao, R. Abu-Elyazeed, S. J. Savarino et al., “High disease burden of diarrhea due to enterotoxigenic Escherichia coli among rural Egyptian infants and young children,” Journal of Clinical Microbiology, vol. 41, no. 10, pp. 4862–4864, 2003. View at: Publisher Site | Google Scholar
  17. G. I. Viboud, M. J. Jouve, N. Binsztein et al., “Prospective cohort study of enterotoxigenic Escherichia coli infections in Argentinean children,” Journal of Clinical Microbiology, vol. 37, no. 9, pp. 2829–2833, 1999. View at: Google Scholar
  18. J. M. Fleckenstein, D. J. Kopecko, R. L. Warren, and E. A. Elsinghorst, “Molecular characterization of the tia invasion locus from enterotoxigenic Escherichia coli,” Infection and Immunity, vol. 64, no. 6, pp. 2256–2265, 1996. View at: Google Scholar
  19. C. Lindenthal and E. A. Elsinghorst, “Identification of a glycoprotein produced by enterotoxigenic Escherichia coli,” Infection and Immunity, vol. 67, no. 8, pp. 4084–4091, 1999. View at: Google Scholar
  20. E. A. Brown and P. R. Hardwidge, “Biochemical characterization of the enterotoxigenic Escherichia coli LeoA protein,” Microbiology, vol. 153, no. 11, pp. 3776–3784, 2007. View at: Publisher Site | Google Scholar
  21. J. M. Fleckenstein, L. E. Lindler, E. A. Elsinghorst, and J. B. Dale, “Identification of a gene within a pathogenicity island of enterotoxigenic Escherichia coli H10407 required for maximal secretion of the heat-labile enterotoxin,” Infection and Immunity, vol. 68, no. 5, pp. 2766–2774, 2000. View at: Publisher Site | Google Scholar
  22. J.-P. Côté and M. Mourez, “Structure-function analysis of the TibA self-associating autotransporter reveals a modular organization,” Infection and Immunity, vol. 79, no. 5, pp. 1826–1832, 2011. View at: Publisher Site | Google Scholar
  23. C. Lindenthal and E. A. Elsinghorst, “Enterotoxigenic Escherichia coli TibA glycoprotein adheres to human intestine epithelial cells,” Infection and Immunity, vol. 69, no. 1, pp. 52–57, 2001. View at: Publisher Site | Google Scholar
  24. K. Roy, D. Hamilton, K. P. Allen, M. P. Randolph, and J. M. Fleckenstein, “The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection,” Infection and Immunity, vol. 76, no. 5, pp. 2106–2112, 2008. View at: Publisher Site | Google Scholar
  25. K. Roy, R. Kansal, S. R. Bartels, D. J. Hamilton, S. Shaaban, and J. M. Fleckenstein, “Adhesin degradation accelerates delivery of heat-labile toxin by enterotoxigenic Escherichia coli,” The Journal of Biological Chemistry, vol. 286, no. 34, pp. 29771–29779, 2011. View at: Publisher Site | Google Scholar
  26. S. K. Patel, J. Dotson, K. P. Allen, and J. M. Fleckenstein, “Identification and molecular characterization of EatA, an autotransporter protein of enterotoxigenic Escherichia coli,” Infection and Immunity, vol. 72, no. 3, pp. 1786–1794, 2004. View at: Publisher Site | Google Scholar
  27. S. Schubert, A. Rakin, H. Karch, E. Carniel, and J. Heesemann, “Prevalence of the “high-pathogenicity island” of Yersinia species among Escherichia coli strains that are pathogenic to humans,” Infection and Immunity, vol. 66, no. 2, pp. 480–485, 1998. View at: Google Scholar
  28. O. G. Gomez-Duarte, Y. C. Romero-Herazo, C. Z. Paez-Canro, J. H. Eslava-Schmalbach, and O. Arzuza, “Enterotoxigenic Escherichia coli associated with childhood diarrhoea in Colombia, South America,” The Journal of Infection in Developing Countries, vol. 7, no. 5, pp. 372–381, 2013. View at: Google Scholar
  29. O. G. Gómez-Duarte, O. Arzuza, D. Urbina et al., “Detection of Escherichia coli enteropathogens by multiplex polymerase chain reaction from children's diarrheal stools in two Caribbean-Colombian cities,” Foodborne Pathogens and Disease, vol. 7, no. 2, pp. 199–206, 2010. View at: Publisher Site | Google Scholar
  30. M. R. Green, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 4th edition, 2012.
  31. O. G. Gómez-Duarte, J. Bai, and E. Newell, “Detection of Escherichia coli, Salmonella spp., Shigella spp., Yersinia enterocolitica, Vibrio cholerae, and Campylobacter spp. enteropathogens by 3-reaction multiplex polymerase chain reaction,” Diagnostic Microbiology & Infectious Disease, vol. 63, no. 1, pp. 1–9, 2009. View at: Publisher Site | Google Scholar
  32. C. Rodas, V. Iniguez, F. Qadri, G. Wiklund, A.-M. Svennerholm, and Å. Sjoling, “Development of multiplex PCR assays for detection of enterotoxigenic Escherichia coli colonization factors and toxins,” Journal of Clinical Microbiology, vol. 47, no. 4, pp. 1218–1220, 2009. View at: Publisher Site | Google Scholar
  33. F. del Canto, P. Valenzuela, L. Cantero et al., “Distribution of classical and nonclassical virulence genes in enterotoxigenic Escherichia coli isolates from Chilean children and tRNA gene screening for putative insertion sites for genomic islands,” Journal of Clinical Microbiology, vol. 49, no. 9, pp. 3198–3203, 2011. View at: Publisher Site | Google Scholar
  34. T. Wirth, D. Falush, R. Lan et al., “Sex and virulence in Escherichia coli: an evolutionary perspective,” Molecular Microbiology, vol. 60, no. 5, pp. 1136–1151, 2006. View at: Publisher Site | Google Scholar
  35. A. Dereeper, V. Guignon, G. Blanc et al., “Phylogeny.fr: robust phylogenetic analysis for the non-specialist,” Nucleic Acids Research, vol. 36, pp. W465–W469, 2008. View at: Publisher Site | Google Scholar
  36. A. Dereeper, S. Audic, J.-M. Claverie, and G. Blanc, “BLAST-EXPLORER helps you building datasets for phylogenetic analysis,” BMC Evolutionary Biology, vol. 10, no. 1, article 8, 2010. View at: Publisher Site | Google Scholar
  37. I. Orskov, F. Orskov, B. Jann, and K. Jann, “Serology, chemistry, and genetics of O and K antigens of Escherichia coli,” Bacteriological Reviews, vol. 41, no. 3, pp. 667–710, 1977. View at: Google Scholar
  38. J. Machado, F. Grimont, and P. A. D. Grimont, “Identification of Escherichia coli flagellar types by restriction of the amplified fliC gene,” Research in Microbiology, vol. 151, no. 7, pp. 535–546, 2000. View at: Publisher Site | Google Scholar
  39. M. M. Levine, P. Ristaino, G. Marley et al., “Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans,” Infection and Immunity, vol. 44, no. 2, pp. 409–420, 1984. View at: Google Scholar
  40. D. G. Evans, R. P. Silver, D. J. Evans Jr., D. G. Chase, and S. L. Gorbach, “Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans,” Infection and Immunity, vol. 12, no. 3, pp. 656–667, 1975. View at: Google Scholar
  41. L. Gonzales, S. Sanchez, S. Zambrana et al., “Molecular characterization of enterotoxigenic Escherichia coli isolates recovered from children with diarrhea during a 4-year period (2007 to 2010) in Bolivia,” Journal of Clinical Microbiology, vol. 51, no. 4, pp. 1219–1225, 2013. View at: Publisher Site | Google Scholar
  42. R. E. Black, M. H. Merson, A. S. Rahman et al., “A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh,” The Journal of Infectious Diseases, vol. 142, no. 5, pp. 660–664, 1980. View at: Google Scholar
  43. F. P. Rivera, T. J. Ochoa, R. C. Maves et al., “Genotypic and phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from peruvian children,” Journal of Clinical Microbiology, vol. 48, no. 9, pp. 3198–3203, 2010. View at: Publisher Site | Google Scholar
  44. B. A. Oyofo, D. S. Subekti, A.-M. Svennerholm et al., “Toxins and colonization factor antigens of enterotoxigenic Escherichia coli among residents of Jakarta, Indonesia,” The American Journal of Tropical Medicine and Hygiene, vol. 65, no. 2, pp. 120–124, 2001. View at: Google Scholar
  45. H. Steinsland, P. Valentiner-Branth, H. M. S. Grewal, W. Gaastra, K. Mølbak, and H. Sommerfelt, “Development and evaluation of genotypic assays for the detection and characterization of enterotoxigenic Escherichia coli,” Diagnostic Microbiology & Infectious Disease, vol. 45, no. 2, pp. 97–105, 2003. View at: Publisher Site | Google Scholar
  46. C. Rodas, R. Mamani, J. Blanco et al., “Enterotoxins, colonization factors, serotypes and antimicrobial resistance of enterotoxigenic Escherichia coli (ETEC) strains isolated from hospitalized children with diarrhea in Bolivia,” Brazilian Journal of Infectious Diseases, vol. 15, no. 2, pp. 132–137, 2011. View at: Publisher Site | Google Scholar
  47. A. C. P. Vicente, L. F. M. Teixeira, L. Iniguez-Rojas et al., “Outbreaks of cholera-like diarrhoea caused by enterotoxigenic Escherichia coli in the Brazilian Amazon Rainforest,” Transactions of the Royal Society of Tropical Medicine & Hygiene, vol. 99, no. 9, pp. 669–674, 2005. View at: Publisher Site | Google Scholar
  48. J. A. Giron, G. I. Viboud, V. Sperandio et al., “Prevalence and association of the Longus pilus structural gene (lngA) with colonization factor antigens, enterotoxin types, and serotypes of enterotoxigenic Escherichia coli,” Infection and Immunity, vol. 63, no. 10, pp. 4195–4198, 1995. View at: Google Scholar
  49. Z. Gutiérrez-Cázarez, F. Qadri, M. J. Albert, and J. A. Girón, “Identification of enterotoxigenic Escherichia coli harboring Longus type IV pilus gene by DNA amplification,” Journal of Clinical Microbiology, vol. 38, no. 5, pp. 1767–1771, 2000. View at: Google Scholar
  50. L. S. Nishimura, J. A. Girón, S. L. Nunes, and B. E. C. Guth, “Prevalence of enterotoxigenic Escherichia coli strains harboring the Longus pilus gene in Brazil,” Journal of Clinical Microbiology, vol. 40, no. 7, pp. 2606–2608, 2002. View at: Publisher Site | Google Scholar
  51. M. G. Pichel, N. Binsztein, F. Qadri, and J. A. Girón, “Type IV Longus pilus of enterotoxigenic Escherichia coli: occurrence and association with toxin types and colonization factors among strains isolated in Argentina,” Journal of Clinical Microbiology, vol. 40, no. 2, pp. 694–697, 2002. View at: Publisher Site | Google Scholar
  52. A. P. Clavijo, J. Bai, and O. G. Gómez-Duarte, “The Longus type IV pilus of enterotoxigenic Escherichia coli (ETEC) mediates bacterial self-aggregation and protection from antimicrobial agents,” Microbial Pathogenesis, vol. 48, no. 6, pp. 230–238, 2010. View at: Publisher Site | Google Scholar
  53. C. P. Guevara, W. B. Luiz, A. Sierra et al., “Enterotoxigenic Escherichia coli (ETEC) CS21 pilus contributes to adhesion to intestinal cells and to pathogenesis under in vivo conditions,” Microbiology, vol. 159, no. 8, pp. 1725–1735, 2013. View at: Publisher Site | Google Scholar
  54. K. Mazariego-Espinosa, A. Cruz, M. A. Ledesma, S. A. Ochoa, and J. Xicohtencatl-Cortes, “Longus, a type IV pilus of enterotoxigenic Escherichia coli, is involved in adherence to intestinal epithelial cells,” Journal of Bacteriology, vol. 192, no. 11, pp. 2791–2800, 2010. View at: Publisher Site | Google Scholar
  55. H. Sommerfeit, H. Steinsland, H. M. S. Grewal et al., “Colonization factors of enterotoxigenic Escherichia coli isolated from children in North India,” The Journal of Infectious Diseases, vol. 174, no. 4, pp. 768–776, 1996. View at: Google Scholar
  56. S. M. Turner, R. R. Chaudhuri, Z.-D. Jiang et al., “Phylogenetic comparisons reveal multiple acquisitions of the toxin genes by enterotoxigenic Escherichia coli strains of different evolutionary lineages,” Journal of Clinical Microbiology, vol. 44, no. 12, pp. 4528–4536, 2006. View at: Publisher Site | Google Scholar
  57. M. K. Wolf, “Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli,” Clinical Microbiology Reviews, vol. 10, no. 4, pp. 569–584, 1997. View at: Google Scholar
  58. A. B. F. Pacheco, B. E. C. Guth, K. C. C. Soares, L. Nishimura, D. F. de Almeida, and L. C. S. Ferreira, “Random amplification of polymorphic DNA reveals serotype-specific clonal clusters among enterotoxigenic Escherichia coli strains isolated from humans,” Journal of Clinical Microbiology, vol. 35, no. 6, pp. 1521–1525, 1997. View at: Google Scholar
  59. N. Al-Gallas, S. M. Abbassi, A. B. Hassan, and R. B. Aissa, “Genotypic and phenotypic profiles of enterotoxigenic Escherichia coli associated with acute diarrhea in Tunis, Tunisia,” Current Microbiology, vol. 55, no. 1, pp. 47–55, 2007. View at: Publisher Site | Google Scholar
  60. M. Ansaruzzaman, N. A. Bhuiyan, Y. A. Begum et al., “Characterization of enterotoxigenic Escherichia coli from diarrhoeal patients in Bangladesh using phenotyping and genetic profiling,” Journal of Medical Microbiology, vol. 56, no. 2, pp. 217–222, 2007. View at: Publisher Site | Google Scholar
  61. M. Nicklasson, J. Klena, C. Rodas et al., “Enterotoxigenic Escherichia coli multilocus sequence types in Guatemala and Mexico,” Emerging Infectious Diseases, vol. 16, no. 1, pp. 143–146, 2010. View at: Publisher Site | Google Scholar

Copyright © 2014 Julio A. Guerra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1809 Views | 782 Downloads | 16 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder